HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yashima, K Articles by Gazdar, A F Search for Related Content PubMed PubMed Citation Articles by Yashima, K Articles by Gazdar, A F

Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes.

Hamon Centre for Therapeutic Oncology Research, UT Southwestern Medical Centre, Dallas 75235-8593, USA.

AIMS/BACKGROUND: Telomerase, an enzyme associated with cellular immortality, is expressed by most malignant tumours, but is inactive in normal somatic cells except for male germ cells and proliferating stem cells. Thus, the measurement of telomerase activity in tissue samples may provide useful diagnostic and prognostic information. The aim of this study was to determine whether telomerase expression is useful for the detection of occult malignant cells in lymph nodes. METHODS: Telomerase activity was compared with histological findings in 123 surgically removed lymph nodes submitted for routine or frozen section diagnosis. Telomerase activity was measured using a modified, semi-quantitative PCR-based telomeric repeat amplification protocol (TRAP). The assay was adapted for single 5 microns OCT embedded cryostat sections. In either fresh tissues or cryostat sections, normalised activity was linear when compared with protein concentration. Furthermore, using an in situ hybridisation method, the human telomerase RNA (hTR) component was measured in a subset of negative and positive nodes. RESULTS: Most (96%) of the 97 histologically negative nodes expressed low levels of activity (mean value of positive samples = 3.0 units/microgram protein) which may be derived from activated lymphocytes that express telomerase activity. All 26 malignant nodes (17 metastases, nine lymphomas) expressed telomerase (mean value = 17.8 units/microgram protein). The rank order levels between the two groups differed significantly (p = 0.0002). In situ results showed clearly that the hTR was expressed relatively highly in metastatic cancer cells and at lower levels in germinal centres of secondary follicles. CONCLUSIONS: Although expression of telomerase by activated lymphocytes may limit its usefulness, measurement of enzyme activity combined with detection of hTR using in situ hybridisation may assist in the histopathological diagnosis of lymph nodes.

This article has been cited by other articles:

				C O'Flatharta, M Leader, E Kay, S R Flint, M Toner, W Robertson, and M J E M F Mabruk Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation J. Clin. Pathol., August 1, 2002; 55(8): 602 - 607. [Abstract] [Full Text] [PDF]

				J. W. Shay, Y. Zou, E. Hiyama, and W. E. Wright Telomerase and cancer Hum. Mol. Genet., April 1, 2001; 10(7): 677 - 685. [Abstract] [Full Text] [PDF]

				K. Aogi, A. Woodman, V. Urquidi, D. C. Mangham, D. Tarin, and S. Goodison Telomerase Activity in Soft-Tissue and Bone Sarcomas Clin. Cancer Res., December 1, 2000; 6(12): 4776 - 4781. [Abstract] [Full Text]

				T. Günther, R. Schneider-Stock, C. Häckel, M. Pross, H.-U. Schulz, H. Lippert, and A. Roessner Telomerase Activity and Expression of hTRT and hTR in Gastrointestinal Stromal Tumors in Comparison with Extragastrointestinal Sarcomas Clin. Cancer Res., May 1, 2000; 6(5): 1811 - 1818. [Abstract] [Full Text]

				B. Heine, S. E Coupland, S. Kneiff, G. Demel, N. Bornfeld, M. Hummel, and H. Stein Telomerase expression in uveal melanoma Br. J. Ophthalmol., February 1, 2000; 84(2): 217 - 223. [Abstract] [Full Text]

				X. Yi, V. M. Tesmer, I. Savre-Train, J. W. Shay, and W. E. Wright Both Transcriptional and Posttranscriptional Mechanisms Regulate Human Telomerase Template RNA Levels Mol. Cell. Biol., June 1, 1999; 19(6): 3989 - 3997. [Abstract] [Full Text] [PDF]

				K.-F. Norrback, G. Enblad, M. Erlanson, C. Sundstrom, and G. Roos Telomerase Activity in Hodgkin's Disease Blood, July 15, 1998; 92(2): 567 - 573. [Abstract] [Full Text] [PDF]

				A. J. Curran, K. St. Denis, J. Irish, P. J. Gullane, C. MacMillan, and S. Kamel-Reid Telomerase Activity in Oral Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, July 1, 1998; 124(7): 784 - 788. [Abstract] [Full Text] [PDF]